Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a Duke Cancer Institute researcher. This newly defined risk -- the first to show a conclusive link ... Read More »
New Guidelines on Endometrial Cancer ‘a Good Road Map’
New guidelines on the diagnosis, treatment, and follow-up of endometrial cancer, the most common gynecologic cancer in developed countries, have been issued jointly by the European Society for Medical Oncology (ESMO), the European Society for Radiotherapy and Oncology (ESTRO), and the European ... Read More »
Biomarker may predict endometrial cancer recurrences
Endometrial cancer is the most common gynecologic cancer in the U.S. Most cases are diagnosed at early stage and have good prognosis. Unfortunately, some patients with early stage and low grade endometrial cancer experience recurrence -- and the reasons are not entirely clear. When recurrence ... Read More »
